Multiple Sclerosis Clinical Trials in Houston

Showing 261-280 of 517 trials

Non Invasive Oral Cancer Screening Among HIV Infected Individuals

NCT02823847

The goal of this clinical research study is to learn how a new method for performing oral (mouth) exams can help doctors check for suspicious lesions (called premalignant and malignant oral lesions \[PMOL\]) in the mouth of HIV-infected smokers.

Malignant Neoplasms of Mesothelial and Soft TissueHuman Immunodeficiency Virus

M.D. Anderson Cancer Center44 participantsStarted Jun 2016

Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

NCT02982941

This study is a Phase 1, open-label, dose escalation and cohort expansion trial designed to characterize the safety, tolerability, PK, PD, immunogenicity and preliminary antitumor activity of enoblituzumab administered IV on a weekly schedule for up to 96 doses (approximately 2 years) in children and young adults with B7-H3-expressing relapsed or refractory malignant solid tumors.

NeuroblastomaRhabdomyosarcomaOsteosarcoma+3 more

MacroGenics25 participantsStarted Dec 2016

Palo Alto, California, United States • Bethesda, Maryland, United States • Philadelphia, Pennsylvania, United States +3 more locations

Non Invasive Oral Cancer Screening Among HIV Infected Individuals

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Multiple Sclerosis Trials in Other Cities

Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors

Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer

Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis

Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment

A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)

Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment

Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis

Prospective Aneurysm Trial: High Angle Aorfix™ Bifurcated Stent Graft

The (PIVOTAL) Study

Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS

Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)

Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)

A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients

A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer

PEN-866 in Patients With Advanced Solid Malignancies

A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

Other Conditions in Houston